Article
Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.
Annals of surgical oncology - 1 Mar 2023
Hussain Zahra, Heaton Martin J, Snelling Andrew P, Nobes Jenny P, Gray Gill, Garioch Jennifer J, Moncrieff Marc D
Abstract excerpt
BACKGROUND: Currently, all patients with American Joint Committee on Cancer (AJCC) pT2b-pT4b melanomas and a positive sentinel node biopsy are now considered for adjuvant systemic therapy without consideration of the burden of disease in the metastatic nodes. METHODS: This was a retrospective cohort analysis of 1377 pT1-pT4b melanoma patients treated at an academic cancer center. Standard variables regarding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
